Primary perivascular epithelioid cell tumor of the liver: new case report and literature review
© Ameurtesse et al.; licensee BioMed Central Ltd. 2014
Received: 6 April 2014
Accepted: 7 July 2014
Published: 17 July 2014
Perivascular epithelioid cell tumors (PEComas) encompass a group of rare mesenchymal neoplasms, which typically have a perivascular location with dual melanocytic and muscular differentiation. They are found in a variety of localizations, though lesions in the liver are exceedingly rare. Because of their rarity, the clinical, radiological and histological features of these tumors have yet to be established. This is why, it seems appropriate to report the observation of this rare hepatic tumor with a literary review including others published cases, assessing through it, clinicopathologic and radiologic features of all reported cases as well as their follow-up whenever possible.
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1967094999126169
KeywordsPEComas Liver neoplasms Perivascular epithelioid cell
Perivascular epithelioid cell neoplasms (PEComas) formed a rare group of related mesenchymal tumors composed of histologically and immunohistochimically distinctive perivascular cells (PECs), first proposed by Bonetti et al. in 1992. The members of this family include angiomyolipoma, lymphangioleiomyomatosis, pulmonary clear cell “sugar” tumors and PEComa-NOS. This last entity, first introduced by Zamboni and al in 1996, to describe neoplasms composed solely of PECs in his case report. Many anatomic sites can be affected, but the uterus is the more common. Cases that arise from the liver are extremely rare. To the best of our knowledge, Only 20 hepatic PEComas, composed solely of PECs, have been reported in the current literature, mostly, as single-case reports.
The following report presents an additional case of primary liver PEComa appearing in a 63-years-old woman, followed by a short synopsis about previously published cases. We discuss the clinicopathological features, the immunophenotype and the differential diagnosis to improve awareness about this type of tumor and how to diagnose it.
A 63-year-old woman presented to gastroenterology department with a 1-year history of atypical pain in the right upper abdominal quadrant, with significant fatigue and weight loss.
On the basis of the morphologic characteristics and immunohistochemical results, a diagnosis of hepatic PEComa was made, with infiltration of the margins.
The patient recovered uneventfully and was discharged 2 weeks after surgery, without any adjuvant treatment. At present, 9 months after the surgery, she is under regular clinical follow-up with no evidence of primary recurrence or metastasis.
For the literature review, a systematic search for PEComa related reports published was performed using PubMed with de keywords: PEComa, perivascular epithelioid cell, angiomyolipoma, liver and HMB45.
We have described a hepatic PEComa composed purely of epithelioid cells with lack of lipocytes and abnormal vessels. In our case, no other component element of the tumour could be found anywhere even though extensive examination of most of the tumour tissue was performed.
The descriptive term “perivascular epithelioid cells (PECs)” were first proposed by Bonetti et al. in 1992 to describe an “unusual atypical cell type” which typically has a perivascular distribution, with dual melanocytic and myoid differentiation. Despite the lack of evidence of a normal anatomical homologue, in 2002, the World Health Organization has given formal recognition to the concept of this novel cell type and of PEC-derived tumors. “PEComa family” includes now many distinct clinicopathologic entities such as angiomyolipoma (AML), lymphangiomyomatosis and clear cell “sugar” tumors of the lung,. Some of them have been linked to tuberous sclerosis complex, especially AML of the kidney. The group comprising solely PECs is rare; it has been discriminated from classic angiomyolipoma by various appellations including monotypic epithelioid AML, clear cell myomelanocytic tumor, primary extrapulmonary sugar tumor, and PEComas-NOS or simple PEComa[5, 6]. The first reported case in the liver was in 2000, when Yamasaki S described this entity diagnosed incidentally in a 30-years-old women. Since, twenty prior case reports were found in a MEDLINE search and we auditioned our case to this data, the main findings for these cases are summarized in Additional file1: Table S1[6–24].
Hepatic PEComa was commonly diagnosed following abdominal pain or mass, occasionally with incidental finding. One case had synchronous GIST. No one had history or symptoms of TSC. The routine laboratory investigations were noncontributory.
There was a marked female predominance (17 women and 4 men), and the mean age at diagnosis was 46.3 years (range 25–60 years). All tumors were presented as a solitary lesion, most often in the right lobe, which poses a clinical and radiological diagnostic challenge. They varied from 0.8-17 cm in greatest dimension (mean 8.1 cm).
PEComas exhibit a wide spectrum of imaging findings. Hepatic PEComas can be of any echogenecity, most often, with abundant blood flow in or surrounding the lesion. As our case, on CT scan, most neoplasms present as hypo intense with significant enhancement on arterial phase. The portal phase was variable. Almost all lesions reported show low-signal on T1-weighted images, high-signal on T2-weighted images. These radiologic findings of hypervascular lesion can be confused, most often, with those of hepatocellular carcinoma or simple haemangioma.
The diagnostic was most often confirmed by pathology finding. PEComa cells are characterized by their perivascular location, often with radial arrangement around the vascular lumen. Typically, tumor cells are epithelioid and spindle-shaped resembling smooth muscle cells, and tend to have abundant clear to eosinophilic pale granular cytoplasm. Few cases are reported with prominent nucleoli and mild nuclear pleomorphism as seen in our case. The presence of melanin pigment is extremely rare, reported only in 3 cases[13, 19, 20].
The most important finding is positive immunostaining with both melanocytic (HMB45 and/or melan A) and smooth muscle (actin and/or desmin) markers. In all reports, there was a diffuse positivity for HMB45. Melan A and SMA were frequently positive. S100 protein, desmin and vimentine were more often negative.
Immunohistochemistry in the differential diagnosis of PEComa tumors
Gastrointestinal stromal tumors
The possibility of metastatic malignant melanoma should always be removed. In the present case, the patient had no history or clinical manifestation of cutaneous or mucosal melanoma. All the more, we had a negative immunostaining with S100 protein. This last protein was expressed in many reported cases[7, 15, 19–21], thereby making the differential diagnosis more difficult.
Although the vast majority of reported PEComa showed a benign course; some are aggressive with locally destructive recurrences, and distant metastasis. To date, defined criteria for malignancy in hepatic PEComa have not been established. Folpe et al. proposed a classification of PEComas into benign, uncertain malignant potential, and malignant based on the presence of seven worrisome histological features: Tumor size > 5 cm, infiltrative growth pattern, high nuclear grade, high cellularity, necrosis, mitotic activity > 1/50 HFP and vascular invasion. Thereby, PEComa with two or more worrisome histologic features should be considered as malignant. Tumors with nuclear neoplasm only or size more than 5 cm only were considered as a neoplasm of uncertain malignant potential. Only one case of malignant PEComa was reported in the liver, in which the diagnosis was established based on the presence of metastasis. The microscopic findings, in this case, were consistent with a benign status except for size more than 5 cm. Seven were thought to have malignant potential according to Folpe’s criteria, but did not exhibit recurrence or metastasis. This might be attributable to the fact that the follow-up durations in these cases were relatively short (3 to 24 month). In our case the patient exhibited two features that favored malignancy, tumor size and infiltrative growth pattern, requiring therefore, a close and long-term follow-up.
There is no specific treatment protocol for hepatic PEComa; the most of neoplasm were surgically treated without any adjuvant therapy.
Primary PEComas of the liver are still a curiosity and therefore the diagnostic approach, treatment modalities and the follow-up are challenging. Their prognosis remains unpredictable; it should be regarded as tumors with uncertain biological potential that require strict and long-term follow-up.
Consent from the patient
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Perivascular epithelioid cell neoplasms
Perivascular epithelial cells
Not otherwise specified
Magnetic resonance imaging
Human melanoma black 45
Smooth muscle actine
Tuberous sclerosis complex.
Gastrointestinal stromal tumor.
We are indebted to Pr JM. Coindre (Bergonie’s Institute, Bordeaux, France) for confirming the diagnosis.
- Fletcher CD, Unni KK, Mertens F: World Health Organization Classification of Tumors of Pathology and genetics of soft tissue and bone. 2002, Lyon, France: IARC Press, 221-222.
- Zamboni G, Pea M, Martignoni G, Zancanaro C, Faccioli G, Gilioli E, Pederzoli P, Bonetti F: Clear cell “sugar” tumor of the pancreas: a novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol. 1996, 20: 722-730.PubMedView Article
- Bonetti F, Pea M, Martignoni G, Zamboni G: PEC and sugar. Am J Surg Pathol. 1992, 16: 307-308.PubMedView Article
- Folpe AL, Kwiatkowski DJ: Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010, 41: 1-15.PubMedView Article
- YU D, Tang S: Hepatic perivascular epithelioid cell tumor: a case report and review of the literature. Inter Med. 2013, 52: 1333-1336.View Article
- Yamasaki S, Tanaka S, Fujii H, Matsumoto T, Okuda C, Watanabe G, Suda K: Monotypic epithelioid angiomyolipoma of the liver. Histopathology. 2000, 36: 451-456.PubMedView Article
- Tryggvason G, Blondal S, Coldin RD, Albrechtsen J, Bjornsson J, Jonasson JG: Epithelioid angiomyolipoma of the liver: case report and review of the literature. APMIS. 2004, 112: 612-616.PubMedView Article
- Parfitt JR, Bella AJ, Izawa JI, Wehrli BM, FRCPC: Malignant Neoplasm of Perivascular Epithelioid Cells of the Liver: late widespread metastasis with long-term follow-up. Arch Pathol Lab-Med. 2006, 130: 1219-1222.PubMed
- Fang SH, Zhou LN, Jin M, Hu JB: Perivascular epithelioid cell tumor of the liver: a report of two cases and review of the literature. World J Gastroenterol. 2007, 13: 5537-5539.PubMedPubMed CentralView Article
- Larbcharoensub N, Karnsombut P, Jatchaval J, Wasutit Y, Nitiyanant P: Primary hepatic clear cell myomelanocytic tumor: case report and review of the literature. APMIS. 2007, 115: 1454-1459.PubMedView Article
- Svajdler M, Bohus P, Goe V, Tkacova V: Perivascular Epithelioid Cell Tumor (PEComa). Cesko slovenska pathologie. 2007, 43: 18-22.
- Zimmermann A, Von der Brelle C, Berger B, Kappelr A, Candinas D: Primary perivascular epithelioid cell tumor of the liver not related to hepatic ligaments: hepatic PEComa as an emerging entity. Histopathology. 2008, 23: 1185-1193.
- Paiva CE, Moraes Neto FA, Agaimy A, Domingues AC, Rogatto SR: Perivascular epithelioid cell tumor of the liver coexisting with a gastrointestinal stromal tumor. World J Gastroenterol. 2008, 14: 800-822.PubMedPubMed CentralView Article
- Strzelczyk JM, Durczynski A, Szymanski D, Jablkowski M, Dworniak D: Sporny3 Sriola. Perivascular epithelioid cell tumors (PEComa) of the liver: report of case. Surg Today. 2009, 39: 916-921.PubMedView Article
- Priola SM, Cataldi A, Marci V, Fava S: Acute abdomen as an unusual presentation of hepatic PEComa: A case report. Tumori. 2009, 95: 123-128.PubMed
- Perez SB: Tumor de cellulas epithelioides perivasculares (PEComa) hepatico. CIR ESP. 2009, 85: 179-189.View Article
- Akitake R, Kimura H, Sekoguchi S, Nakamura H, Seno H, Chiba T, Fujimoto S: Perivascular epithelioid cell tumors (PEComa) of the liver diagnosed by contrast-enhanced ultrasonography. Inter Med. 2009, 48: 2083-2086.View Article
- Wen MC, Jan YJ, Li MC, Wang J, Lin A: Monotypic epithelioid angiomyolipoma of the liver with TFE3 expression. Pathology. 2010, 42: 300-302.PubMedView Article
- Ahn JH, Bang H: Primary perivascular epithelioid cell tumor (PEComa) of the liver: A case report and review of the literature. Korean J Pathol. 2011, 45: 93-97.View Article
- Jafari A, Fischer HP, Websky MV, Hong GS, Kalff JC, Manekeller SZ: Primary perivascular epitheloid cell tumour (PEComa) of the liver: case report and review of the literature. Gastroenterol. 2013, 51: 1096-1100.View Article
- Cheung TT, Smith NT, Poon RTP: Primary perivascular epithelioid cell tumor (PEComa) of the liver. BMJ Case Rep. 2013, doi:10.1136/bcr-2013-008706
- Zhao LJ, Yang YJ, WU H, Huang SM, UU K: Perivascular epithelioid cell tumor of the liver: a case report and literature review. Eur Rev Med Pharmacol Sci. 2013, 17: 1665-1668.PubMed
- Patra S, Vij M, Kota V, Kancherla R, Rela M: Pigmented perivascular epithelioid cell tumor of the liver: Report of a rare case with brief review of literature. J Can Res Ther. 2013, 9: 305-307.View Article
- Sheng HQ, Chen DF, Sun XH, Li X, Xu J, Hu XB, Li MQ, Zhang RY, Li KZ: MRI diagnostic of perivascular epithelioid cell tumor (PEComa) of the liver. Rom J Morphol Embryol. 2013, 54: 643-647.
- Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW: Perivascular epithelioid cell neoplasm of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the lliterature. Am J Surg Pathol. 2005, 29: 1558-1575.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.